Press release
EPO biomarkers Market Trends 2018 | Segmentation, Outlook, Industry Report to 2023
Request a Free Sample of our EPO biomarkers Market: https://www.omrglobal.com/request-sample/epo-biomarkers-market
Major factors contributing to the growth of the global EPO biomarkers market include increasing sedentary lifestyle and faulty dietary habits has increased the prevalence of cancers and chronic kidney diseases in the emerged economies. Moreover, the increasing incidence of end-stage renal disorders and hematological diseases is further increasing the demand for EPO biomarkers. The patent expiration of EPO biomarkers is significantly increasing the introduction of novel EPO biomarkers in the market. However, the lack of quality control testing laboratories in emerging economies such as India and China is a major factor hindering the growth of the market. Improper price capping regulations across the globe is another factor that is significantly responsible in hampering the growth of the global EPO biomarkers market. However, the favorable healthcare regulations in emerged economies such as the U.S. and rising prevalence of chronic diseases such as cancer is expected to fuel the market growth in the near future.
The EPO Biomarkers Market can be segmented on the basis of biomarker type, applications, and end users. Based on biomarker type, the market is segmented into erythropoietin alfa, erythropoietin beta, erythropoietin zeta, erythropoietin theta, recombinant human erythropoietin, and darbepoietin alfa. Based on application, the market is bifurcated into end-stage renal disorder, cancers, rheumatoid arthritis, AIDS, myelodysplastic syndrome, neurology, hematology, and others (anaemia of chronic inflammatory syndromes). Based on end users, the market is segmented into diagnostic centers, ambulatory care and surgical centers, and hospitals. Among biomarker type, the erythropoietin alfa segment holds a major share in the global EPO biomarkers market. This is owing to increasing adoption in the treatment of chronic renal disorders and cancer.
The global EPO biomarkers market is further analyzed on the basis of the geographical regions that are contributing significantly towards the growth of the market. North America holds a dominant position in the global EPO biomarkers market, followed by Europe. This is mainly owing to the developed healthcare infrastructure in the region. Moreover, the systematic initiatives taken by the government in the research and development activities is one of the major factors contributing in the growth of the EPO biomarkers market in the region. Asia Pacific is projected to exhibit the fastest growth in the global market over the forecast period. Some of the major factors that are significantly contributing in the growth of the market in Asia Pacific are low cost of treatment therapy and increasing incidence rate of hematological diseases in the region, especially in India, China, Pakistan, and Bangladesh.
A full Report of EPO biomarkers Market is Available at: https://www.omrglobal.com/industry-reports/epo-biomarkers-market
EPO biomarkers MARKET SEGMENTATION
BY BIOMARKERTYPE
•
ERYTHROPOIETINALFA
ERYTHROPOIETINBETA
ERYTHROPOIETINZETA
ERYTHROPOIETINTHETA
RECOMBINANTHUMANERYTHROPOIETIN
DARBEPOIETINALFA
BYAPPLICATIONS
•
END-STAGERENALDISORDER
CANCERS
RHEUMATOIDARTHRITIS
AIDS
MYELODYSPLASTICSYNDROME
NEUROLOGY
HEMATOLOGY
OTHERS (ANAEMIA OF CHRONIC INFLAMMATORY SYNDROMES)
BYENDUSERS
DIAGNOSTICCENTERS
AMBULATORYCAREANDSURGICALCENTERS
HOSPITALS
•
COMPETITIVELANDSCAPE
•
KEYMARKETSTRATEGIES
KEYCOMPANYANALYSIS
REGIONALANALYSIS
•
NORTHAMERICAN
UNITEDSTATES
CANADA
EUROPE
U.K
GERMANY
ITALY
SPAIN
FRANCE
ROE
ASIAPACIFIC
INDIA
CHINA
JAPAN
ROAPAC
REST OF THE WORLD
COMPANYPROFILES
•
3SBIOGROUP
AGILENTTECHNOLOGIES, INC.
AMGENINC.
BIOAGILYTIXLABS
BIOCON
BIO-RADLABORATORIES, INC.
EVETECHNOLOGIES
F. HOFFMANN-LAROCHELTD
GALENICAAG
GENSCRIPT
GLAXOSMITHKLINEPLC.
INTASPHARMACEUTICALSLTD.
JOHNSON&JOHNSONSERVICES, INC.
KYOWAHAKKOKIRINCO., LTD.
LGLIFESCIENCESPVTLTD
MERCKKGAA
MYRIADRBM
NOVARTISAG
PACIFICBIOMARKERS
PFIZERINC.
SANDOZINTERNATIONALGMBH
SHANDONGKEXING
SIEMENSAG
THERMO FISHER SCIENTIFIC
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/epo-biomarkers-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based service
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release EPO biomarkers Market Trends 2018 | Segmentation, Outlook, Industry Report to 2023 here
News-ID: 2221188 • Views: …
More Releases from Orion Market Research
North American Cardiovascular Devices Market to Witness Growth Acceleration by 2 …
North American cardiovascular devices market is projected to grow at a significant CAGR of 5.6% during the forecast period. The market growth in North America can be attributed to the rising geriatric population, frequent US FDA approvals for innovative cardiovascular devices, and the growing adoption of minimally invasive/non-invasive cardiac surgeries. There are several cardiac health organizations working in the US, such as American Heart Association. The geriatric population is more…
Topical Drug Delivery Market Will Exhibit an Impressive Expansion by 2024-2031
The global topical drug delivery market is anticipated to grow at a considerable CAGR of 6.1% during the forecast period. The key factor contributing to the market growth includes the increasing approvals, grants, and clearance by government authorities and regulatory bodies for topical drugs. For instance,
• In July 2022, Alembic Pharmaceuticals, (Aleor Dermaceuticals) received the US Food and Drug Administration (US FDA) approval for its Abbreviated New Drug Application (ANDA) for…
Surgical Retractors Market Size, Trends, Latest Insights, Analysis and Forecast …
The global surgical retractors market is anticipated to grow at a considerable CAGR of 6.3% during the forecast period. The increasing research and development activities for the development of new and advanced medical devices by the pharmaceutical and biotechnology companies. Increasing demand for the new surgical devices by the end-users are key factors that are contributing to the growth of the surgical retractors market. For instance,
• In June 2022, U.S.…
Medical Packaging Market Size, Trends, Latest Insights, Analysis and Forecast 20 …
The global medical packaging market is anticipated to grow with a significant CAGR of 6.1% during the forecast period. The growth of the medical packaging market is attributed to the rapidly changing healthcare industry. The medical packaging market is continuously experiencing various changes owing to the outbreak of new diseases, increasing regulatory norms, and growth in advanced healthcare systems. Furthermore, increasing development in diagnostics, pathological and other allied medical equipment…
More Releases for EPO
Global EPO Biomarkers Market Share: Trends, Key Players, Industry Analysis Repor …
The global EPO Biomarkers market is anticipated to grow at a modest CAGR of around 5.3% during the forecast period (2021-2027). EPO is produced by the kidneys and is a factor responsible for regulating red blood cell (RBC) production in mammals. Some of the EPO biomarkers available in the market are epoetin alfa, epoetin beta, epoetin zeta, epoetin theta, recombinant human erythropoietin, and darbepoetin alfa. Among these, the erythropoietin alfa…
EPO Biomarkers Market : Industry Research, Study, Growth Analysis Report 2019 & …
Researchmoz added Most up-to-date research on “Global EPO Biomarkers Market Size, Status and Forecast 2019-2025” to its huge collection of research reports.
The EPO Biomarkers market report [6 Year Forecast 2019-2025] focuses on Major Leading Industry Players, providing info like company profiles, product type, application and regions, production capacity, ex-factory price, gross margin, revenue, market share and speak to info. Upstream raw materials and instrumentation and downstream demand analysis is…
Global EPO Biomarkers Market Research and Forecast 2018-2023
Global EPO biomarkers market size, market intelligence, market trends, research and analysis report by biomarker (erythropoietin alfa, beta, zeta, theta, recombinant human erythropoietin, darbepoetin alfa) by applications (end-stage renal disorder, cancers, rheumatoid arthritis, aids, myelodysplastic syndrome, neurology, hematology) forecast 2018-2023
According to the OMR analysis, the global EPO biomarkers Market is expected to grow impressively during 2018-2023. The global EPO biomarkers market is segmented on the basis of biomarker type, applications,…
EPO Biosimilars - The Future of Erythropoietin Market
ReportsWorldwide has announced the addition of a new report title EPO Biosimilars - The Future of Erythropoietin Market to its growing collection of premium market research reports.
Erythropoietin is a hormone produced by healthy kidneys. This hormone prompts the bone marrow to make the red blood cells, which then carry oxygen throughout the body. Erythropoietin is used to treat anemia resulting from kidney failure or cancer treatment. It is considered to…
Global Erythropoietin (EPO) Market - Johnson & Johnson, Roche, Kyowa Hakko Kirin …
Erythropoietin market, also known as EPO, hematopoietin, or hemopoietin, is a glycoprotein hormone that controls erythropoiesis, or red blood cell production. It is a cytokine (protein signaling molecule) for erythrocyte (red blood cell) precursors in the bone marrow. Human EPO has a molecular weight of 34 kDa.
Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in…
Global Erythropoietin (EPO) Market with Focus on Asia: Industry Analysis & Outlo …
Erythropoietin is a substance produced by the kidney that leads to the formation of red blood cells in the bone marrow. It is a glycoprotein hormone which regulates erythropoiesis (Red Blood Cell production). For erythrocyte precursors present in the bone marrow, EPO acts as a cytokine. Commonly referred to as hematopoietin or hemopoietin, erythropoietin is also known to have other biological functions, such as involvement in the wound healing cycle…
